A new daily pill could provide an easier, more convenient way to lower cholesterol and reduce heart attack and stroke risk. The experimental medication, called Obicetrapib, underwent a Phase 3 ...

Respiratory infections are among the leading causes of illness and death in the elderly, driven by immune aging, chronic ...

Mechanical cues are key regulators of cardiac development, yet their role in organoid maturation remains underexplored. In a ...

The committee will examine how research on experimental fires can be improved to strengthen fire and smoke models for prescribed burns. The committee will: Identify relevant agency research projects ...

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can increase the risk of heart attacks and strokes. Many Americans are unaware that ...